Advertisement
Neurology®
The most widely read and highly cited peer-reviewed Neurology journal
Quick Search
Advanced Search
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow Correspondence:
Submit a response
Right arrow Correspondence:
View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow My Folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kelly, P. J.
Right arrow Articles by Furie, K. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kelly, P. J.
Right arrow Articles by Furie, K. L.
Related Collections
Right arrow All Cerebrovascular disease/Stroke
Right arrow Risk factors in epidemiology
Right arrow Infarction

Neurology 2002;59:529-536
© 2002 American Academy of Neurology

Homocysteine, MTHFR 677C->T polymorphism, and risk of ischemic stroke

Results of a meta-analysis
P. J. Kelly, MB MRCPI, J. Rosand, MD, J. P. Kistler, MD, V. E. Shih, MD, S. Silveira, BA, A. Plomaritoglou, MD and K. L. Furie, MD MPH

From the Stroke Service (Drs. Kelly, Rosand, Kistler, Plomaritoglou, and Furie and S. Silveira) and the Amino Acid Laboratory (Dr. Shih), Department of Neurology, Massachusetts General Hospital and Harvard University, Boston.

Address correspondence and reprint requests to Dr. Kelly, Stroke Service, Department of Neurology, VBK 802, Massachusetts General Hospital, Fruit Street, Boston, MA 02114; e-mail: pjkelly{at}partners.org

Background: Data are conflicting concerning risk for ischemic stroke associated with hyperhomocyst(e)inemia (hyper-Hcy) and a common polymorphism in the gene encoding 5,10-methylenetetrahydrofolate reductase (MTHFR 677C->T), which predisposes to hyper-Hcy in vivo.

Methods: Search of MEDLINE, Science Citation Index, and abstracts of conference proceedings revealed relevant articles. Exposure was defined as follows: 1) prevalence of hyper-Hcy; 2) absolute difference in the mean Hcy concentration between subjects with and without ischemic stroke; and 3) the MTHFR TT genotype frequency. Outcome was defined as ischemic stroke with or without neuroimaging. Inclusion criteria were retrospective and prospective studies with reported odds ratios (OR) or hazard ratios (HR) or arithmetic mean Hcy levels. Exclusion criteria were absence of OR or HR, outcome defined as carotid atherosclerosis or intima–media thickening, stroke in patients younger than 18 years old, and studies in languages other than English. Statistical analyses for between-study heterogeneity and pooled risk estimates were performed using Stata software (Stata Corporation, College Station, TX).

Results: Among 16 studies (1,487 stroke and 2,554 nonstroke cases), the pooled mean Hcy level in patients with ischemic stoke was 2.32 µmol/L (95% CI, 1.6 to 3.04; p < 0.001) greater than that in those without ischemic stroke. Among 14 included studies (1,769 stroke and 7,400 nonstroke cases), the pooled OR estimate of ischemic stroke associated with hyper-Hcy was 1.79 (95% CI, 1.61 to 2.0; p < 0.001). Among 19 included studies (2,788 stroke and 3,962 nonstroke cases), the OR associated with the TT genotype was 1.23 (95% CI, 0.96 to 1.58; p = 0.1).

Conclusion: These data support an association between mild-to-moderate hyper-Hcy and ischemic stoke. The MTHFR TT genotype may have a small influence in determining susceptibility to ischemic stoke.




This article has been cited by other articles:


Home page
CephalalgiaHome page
G. Tietjen, N. Herial, C Utley, L White, S Yerga-Woolwine, and B Joe
Association of von Willebrand Factor Activity with ACE I/D and MTHFR C677T Polymorphisms in Migrainecha
Cephalalgia, September 1, 2009; 29(9): 960 - 968.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
M. Folstein, T. Liu, I. Peter, J. Buel, L. Arsenault, T. Scott, and W. W. Qiu
The Homocysteine Hypothesis of Depression
Am J Psychiatry, June 1, 2007; 164(6): 861 - 867.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
A. Di Rocco, P. Werner, R. B. Postuma, and A. E. Lang
VITAMINS AND ENTACAPONE IN LEVODOPA-INDUCED HYPERHOMOCYSTEINEMIA: A RANDOMIZED CONTROLLED STUDY
Neurology, April 24, 2007; 68(17): 1440 - 1441.
[Full Text] [PDF]


Home page
J Child NeurolHome page
E. A. Vagiakou, K. A. Voudris, Y. Dimitriou, A. Skardoutsou, and S. Mastroyianni
Different Additional Risk Factors for Cerebral Infarctions Associated With the Factor V Leiden Mutation in a Family
J Child Neurol, October 1, 2006; 21(10): 903 - 907.
[Abstract] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
A Pezzini, M Grassi, E Del Zotto, D Assanelli, S Archetti, R Negrini, L Caimi, and A Padovani
Interaction of homocysteine and conventional predisposing factors on risk of ischaemic stroke in young people: consistency in phenotype-disease analysis and genotype-disease analysis
J. Neurol. Neurosurg. Psychiatry, October 1, 2006; 77(10): 1150 - 1156.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
R. B. Postuma, A. J. Espay, C. Zadikoff, O. Suchowersky, W.R.W. Martin, A. -L. Lafontaine, R. Ranawaya, R. Camicioli, and A. E. Lang
Vitamins and entacapone in levodopa-induced hyperhomocysteinemia: A randomized controlled study
Neurology, June 27, 2006; 66(12): 1941 - 1943.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
D. Feinbloom and K. A. Bauer
Assessment of Hemostatic Risk Factors in Predicting Arterial Thrombotic Events
Arterioscler Thromb Vasc Biol, October 1, 2005; 25(10): 2043 - 2053.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
S. Cronin, K. L. Furie, and P. J. Kelly
Dose-Related Association of MTHFR 677T Allele With Risk of Ischemic Stroke: Evidence From a Cumulative Meta-Analysis
Stroke, July 1, 2005; 36(7): 1581 - 1587.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
B. Van Guelpen, J. Hultdin, I. Johansson, B. Stegmayr, G. Hallmans, T. K. Nilsson, L. Weinehall, C. Witthoft, R. Palmqvist, and A. Winkvist
Folate, Vitamin B12, and Risk of Ischemic and Hemorrhagic Stroke: A Prospective, Nested Case-Referent Study of Plasma Concentrations and Dietary Intake
Stroke, July 1, 2005; 36(7): 1426 - 1431.
[Abstract] [Full Text] [PDF]


Home page
ANGIOLOGYHome page
A. B. Sobol, E. Bald, and J. Loba
Fractions of Total Plasma Homocysteine in Patients with Ischemic Stroke Before the Age of 55 Years
Angiology, March 1, 2005; 56(2): 201 - 209.
[Abstract] [PDF]


Home page
StrokeHome page
A. Pezzini, M. Grassi, E. D. Zotto, S. Archetti, R. Spezi, V. Vergani, D. Assanelli, L. Caimi, and A. Padovani
Cumulative Effect of Predisposing Genotypes and Their Interaction With Modifiable Factors on the Risk of Ischemic Stroke in Young Adults
Stroke, March 1, 2005; 36(3): 533 - 539.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. Frederiksen, K. Juul, P. Grande, G. B. Jensen, T. V. Schroeder, A. Tybjaerg-Hansen, and B. G. Nordestgaard
Methylenetetrahydrofolate reductase polymorphism (C677T), hyperhomocysteinemia, and risk of ischemic cardiovascular disease and venous thromboembolism: prospective and case-control studies from the Copenhagen City Heart Study
Blood, November 15, 2004; 104(10): 3046 - 3051.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
R. B. Postuma and A. E. Lang
Homocysteine and levodopa: Should Parkinson disease patients receive preventative therapy?
Neurology, September 14, 2004; 63(5): 886 - 891.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
G. J. Hankey and J. W. Eikelboom
Folic Acid-Based Multivitamin Therapy to Prevent Stroke: The Jury Is Still Out
Stroke, August 1, 2004; 35(8): 1995 - 1998.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
B. Voetsch and J. Loscalzo
Genetic Determinants of Arterial Thrombosis
Arterioscler Thromb Vasc Biol, February 1, 2004; 24(2): 216 - 229.
[Abstract] [Full Text]


Home page
JAMAHome page
D. G. Hackam and S. S. Anand
Emerging Risk Factors for Atherosclerotic Vascular Disease: A Critical Review of the Evidence
JAMA, August 20, 2003; 290(7): 932 - 940.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
L. El-Khairy, S. E. Vollset, H. Refsum, and P. M. Ueland
Plasma Total Cysteine, Mortality, and Cardiovascular Disease Hospitalizations: The Hordaland Homocysteine Study
Clin. Chem., June 1, 2003; 49(6): 895 - 900.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
P. J. Kelly, V. E. Shih, J. P. Kistler, M. Barron, H. Lee, R. Mandell, and K. L. Furie
Low Vitamin B6 but Not Homocyst(e)ine Is Associated With Increased Risk of Stroke and Transient Ischemic Attack in the Era of Folic Acid Grain Fortification
Stroke, June 1, 2003; 34 (6): e51 - e54.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
U. B. Fallon, J. Virtamo, I. Young, D. McMaster, Y. Ben-Shlomo, N. Wood, A. S. Whitehead, and G. D. Smith
Homocysteine and Cerebral Infarction in Finnish Male Smokers
Stroke, June 1, 2003; 34(6): 1359 - 1363.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
U. B. Fallon, Y. Ben-Shlomo, P.J. Kelly, J. Rosand, V. Shih, J. Kistler, and K.L. Furie
Homocysteine, MTHFR 677C->T polymorphism, and risk of ischemic stroke: Results of a meta-analysis
Neurology, February 11, 2003; 60(3): 526 - 527.
[Full Text] [PDF]


Home page
StrokeHome page
M. J. Alberts
Stroke Genetics Update
Stroke, February 1, 2003; 34(2): 342 - 344.
[Full Text] [PDF]


Home page
NeurologyHome page
P.J. Kelly, K.L. Furie, J.P. Kistler, M. Barron, E.H. Picard, R. Mandell, and V.E. Shih
Stroke in young patients with hyperhomocysteinemia due to cystathionine beta-synthase deficiency
Neurology, January 28, 2003; 60(2): 275 - 279.
[Abstract] [Full Text] [PDF]


Home page
Vasc MedHome page
F. L Ruberg and J. Loscalzo
Prothrombotic determinants of coronary atherothrombosis
Vascular Medicine, November 1, 2002; 7(4): 289 - 299.
[Abstract] [PDF]


Home page
JWatch NeurologyHome page
Homocysteine, MTHFR 677C->T Polymorphism, and Ischemic-Stroke Risk
Journal Watch Neurology, October 24, 2002; 2002(1024): 3 - 3.
[Full Text]

Correspondence:

Read all Correspondence

Homocysteine, MTHFR 677CT polymorphism, and risk of ischemic stroke: Results of a
Una Fallon, et al.
Neurology Online, 13 Nov 2002 [Full text]
Reply to Letter to the Editor
Peter J Kelly, et al.
Neurology Online, 13 Nov 2002 [Full text]


Advertisement